Heart failure with normal ejection fraction (HeFNEF) accounts for ~50% of heart failure admissions. Its pathophysiology and diagnostic criteria are yet to be defined clearly which may hinder the search for effective treatments. The clinical hallmark of HeFNEF is exertional breathlessness, often due to an abnormal increase in left atrial pressure during exercise. Creation of an interatrial communication to offload the left atrium is a possible therapeutic approach. There are two percutaneously delivered devices currently under investigation which are discussed in this review.
CITATION STYLE
Cuthbert, J. J., Pellicori, P., & Clark, A. L. (2017, June 2). Interatrial shunt devices for heart failure with normal ejection fraction: A technology update. Medical Devices: Evidence and Research. Dove Medical Press Ltd. https://doi.org/10.2147/mder.s113105
Mendeley helps you to discover research relevant for your work.